These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8001041)

  • 1. The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
    Vander Heide RS; Schwartz LM; Reimer KA
    Cardiovasc Res; 1994 Oct; 28(10):1526-32. PubMed ID: 8001041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infarct size-limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel, in anesthetized rats: comparison with verapamil.
    Richard V; Tron C; Blanc T; Thuillez C
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):552-7. PubMed ID: 7596122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique cardioprotective action of the new calcium antagonist mibefradil.
    Schulz R; Post H; Jalowy A; Backenköhler U; Dörge H; Vahlhaus C; Heusch G
    Circulation; 1999 Jan; 99(2):305-11. PubMed ID: 9892599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
    Auchampach JA; Grover GJ; Gross GJ
    Cardiovasc Res; 1992 Nov; 26(11):1054-62. PubMed ID: 1291082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning with supply-demand imbalance limits infarct size in dog heart.
    Iwamoto T; Bai XJ; Downey HF
    Cardiovasc Res; 1993 Nov; 27(11):2071-6. PubMed ID: 8287420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
    Billman GE
    Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
    Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
    Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
    Hoshida S; Kuzuya T; Nishida M; Yamashita N; Oe H; Hori M; Kamada T; Tada M
    Cardiovasc Res; 1994 Jul; 28(7):1083-8. PubMed ID: 7954595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil.
    Clozel JP; Banken L; Osterrieder W
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):713-21. PubMed ID: 2481185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
    Muller CA; Opie LH; McCarthy J; Hofmann D; Pineda CA; Peisach M
    J Am Coll Cardiol; 1998 Jul; 32(1):268-74. PubMed ID: 9669280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premedication with the opioid analgesic butorphanol raises the threshold for ischemic preconditioning in dogs.
    Schwartz LM; Jennings RB; Reimer KA
    Basic Res Cardiol; 1997 Apr; 92(2):106-14. PubMed ID: 9166990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulations in glycogen metabolism and the failure to influence infarct size in the ischaemic rabbit heart.
    Gozal Y; Wolff RA; Van Winkle DM
    Eur J Anaesthesiol; 2002 Jul; 19(7):495-503. PubMed ID: 12113612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No attenuation of ischaemic preconditioning by the calcium antagonist nisoldipine.
    Wallbridge DR; Schulz R; Braun C; Post H; Heusch G
    J Mol Cell Cardiol; 1996 Aug; 28(8):1801-10. PubMed ID: 8877789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of catecholamine depletion on myocardial infarct size in dogs: role of catecholamines in ischemic preconditioning.
    Vander Heide RS; Schwartz LM; Jennings RB; Reimer KA
    Cardiovasc Res; 1995 Nov; 30(5):656-62. PubMed ID: 8595609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism.
    Mocanu MM; Gadgil S; Yellon DM; Baxter GF
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):115-22. PubMed ID: 10372226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
    Shimizu M; Wang QD; Sjöquist PO; Rydén L
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit.
    Tanaka M; Fujiwara H; Yamasaki K; Sasayama S
    Cardiovasc Res; 1994 Jul; 28(7):980-6. PubMed ID: 7954610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure.
    Su J; Renaud N; Carayon A; Crozatier B; Hittinger L
    Br J Pharmacol; 1994 Oct; 113(2):395-402. PubMed ID: 7834190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.